Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New Services Launched to Help People Achieve a Healthier Weight and Improve Wellbeing
Thousands of adults and children will benefit from new services launched across England to help […]
90% of UK’s Leading Health Providers Accelerate Digital Transformation Plans in Response to Covid-19
The UK health sector is fast accelerating its digital transformation plans in response to the […]
Electroducer Announces Major Medical Advance in Treatment of Heart Valve Disease; Raises €3 Million to Market its Device in Europe and US – Commencing in 2022
Electroducer, the designer and developer of the innovative medical device Electroducer Sleeve®, which treats heart […]
COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research […]
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
OnCusp Therapeutics (or “OnCusp”), a global biopharmaceutical company focused on translating cutting-edge research assets into […]
SHINE Medical Technologies Closes $150-million Series C-5 Financing to Advance Nuclear Fusion-Based Technologies
SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. […]
Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology
Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]
Presidio Medical Announces Appointment of New Chief Executive Officer
Presidio Medical, Inc., a clinical-stage medical device company developing a transformational neuromodulation platform, today announced […]
Roche’s ENSPRYNG Approved by European Commission as First and Only At-home Subcutaneous Treatment for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved […]
Kite Announces Yescarta® CAR T-cell Therapy Improved Event-Free Survival by 60% Over Chemotherapy Plus Stem Cell Transplant in Second-Line Relapsed or Refractory Large B-cell Lymphoma
Kite, a Gilead Company (Nasdaq: GILD), today announced top-line results from the primary analysis of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more